Press release
MEDraysintell to showcase its reports at SNNMI in Denver
MEDraysintell will display its series of market reports and directories with over 1,900 pages of unrivaled intelligence covering Nuclear Medicine, Cyclotrons, Brachytherapy and Proton Therapy, during the SNMMI – Society of Nuclear Medicine and Molecular Imaging– congress (Denver, CO, USA, June 10-14, 2017), www.snmmi.org/am2017MEDraysintell is gratefully hosted by the company ANMI and visitors are welcome at booth #957.
MEDraysintell estimates the global market for nuclear medicine (radiopharmaceuticals) has reached US$ 4.5 billion in 2016, growing by about 5% from 2015; and with the recent M&A activities, the top five companies share about 65% of the world market.
“Nuclear Medicine World Market Report & Directory” is a 990-page report providing an exhaustive description and analysis of over 370 radiopharmaceuticals and radionuclides with a comprehensive profile of more than 170 companies and institutions active in the radiopharmaceuticals industry. A new Edition 2017 will be available during the summer.
“Cyclotrons used in Nuclear Medicine World Market Report & Directory” is a 350-page report providing an extensive review of all cyclotrons around the world (over 1,200) with an exhaustive profile of the 14 companies active in this market.
“Brachytherapy Market Report & Directory Global” provides in a 340-page document a complete description of the radionuclides and devices used in brachytherapy, and a detailed profile of 62 companies and institutions active in this field around the world.
“Proton Therapy World Market Report & Directory” provides in a 290-page document the most comprehensive evaluation of the proton therapy market dynamics on a world basis. It analyzes both past and future trends to the year 2030, and contains a detailed profile of more than 25 promoters, manufacturers or developers of proton and carbon therapy equipment.
MEDraysintell reports and directories are becoming the sole trusted sources of intelligence in the radiation healthcare industry. Reports can be customized to specific areas or modalities. Sample pages and complete table of contents are available upon request. MEDraysintell also welcomes your requests for specific intelligence needs in these areas.
We look forward to seeing you in Denver!
About MEDraysintell
MEDraysintell is a team of international experts providing first-rate strategic intelligence in nuclear medicine, radiotherapy, proton therapy and brachytherapy.
We offer the most comprehensive set of reports and directories, with over 1,900 pages of unrivaled intelligence covering some of the most exciting healthcare technologies using radiation for diagnosis and treatment. We offer client-specific intelligence in the field of radiation healthcare, with the upmost knowledge leveraging our extended network of worldwide contacts. We are proud to support numerous companies globally, helping them better understand the markets, competitive environment as well as the potential of merger and acquisitions (M&A) and technology development. We have repeat satisfied clients operating in the field of medical radiation, investment banks and institutional investors, large international consulting firms and universities research laboratories.
MEDraysintell was created in 2013 by Paul-Emmanuel Goethals and Richard Zimmermann. It combines over 40 years of experience in radiation healthcare. www.medraysintell.com
Paul-Emmanuel Goethals, MBA
Chemin du Cyclotron, 6
1348 Louvain-la-Neuve, Belgium
peg@medraysintell.com
Mobile: +32 491 080 968
Richard Zimmermann, PhD
Lalaye, France
rz@medraysintell.com
Mobile: +33 6 82 80 06 00
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MEDraysintell to showcase its reports at SNNMI in Denver here
News-ID: 554931 • Views: …
More Releases from MEDraysintell

Proton Therapy Industry, a first consolidation in a niche market
With the recent announcement of Hitachi to acquire the particle therapy business of Mitsubishi, we observe the first consolidation in the PT industry. Following this recent announcement, the top three vendors share now 70% of the PT market in 2017 valued at US$ 0.9 billion. Several companies are expected to enter the market for the first time in the coming years with their own PT systems. The global PT market…

MEDraysintell downgrades its proton therapy market projection
In light of several factors summarized below, MEDraysintell is downgrading its proton therapy market projection from 1,200 proton therapy treatment rooms that were expected to be operational in 2030 to 900. This still represents a 12% annual growth from 2017 to 2030 and the need to open an average of more than 50 PT treatment rooms every year from 2018 to 2030.
Originally MEDraysintell expected 2015 to become the starting point…

Future and Economics of Nuclear Medicine
Need to understand future and economics of Nuclear Medicine? Looking for experts in this field? Trying to appreciate the potential of this new technology?
MEDraysintell will display its series of market reports and directories with over 2,100 pages of unrivaled intelligence covering Nuclear Medicine, Cyclotrons, Brachytherapy and Proton Therapy, during the EANM – European Association of Nuclear Medicine – congress (Vienna, Austria, October 21-25, 2017). MEDraysintell is gratefully hosted by the…

Impulse from radiotherapeutics confirms accelerated growth of nuclear medicine
MEDraysintell releases its new Nuclear Medicine World Market Report and Directory–Edition 2017, a 1,100-page document that provides an exhaustive description and analysis of more than 390 products, including over 140 radiopharmaceuticals under clinical development, with a comprehensive profile of 193 companies and institutions active in the radiopharmaceuticals industry.
Detailed table of contents and sample pages available upon request a peg@medraysintell.com
MEDraysintell estimates that the global market for nuclear medicine reached US$ 4.5…
More Releases for Denver
Liposuction Denver Rated Best Liposuction Services in Denver - Setting the Stand …
Image: https://www.globalnewslines.com/uploads/2025/07/1752122335.jpg
Denver, CO - July 10, 2025 - Liposuction Denver, the city's leading destination for advanced body contouring and fat removal procedures, has officially been rated the Best Liposuction Services in Denver for 2025. With a growing reputation for outstanding results, compassionate care, and cutting-edge techniques, Liposuction Denver continues to redefine what patients can expect when they search for the best liposuction in Denver.
Backed by a team of highly trained…
Vinyl Banners in Denver Now Offered by Denver Print Company
Image: https://www.globalnewslines.com/uploads/2025/03/1741702916.jpg
DENVER, Colorado - Denver Print Company [https://www.denverprintingcompany.com/denver-print-services/wide-format-printing/vinyl-banners/], a locally-owned and minority-certified printing business, announces expanded services for vinyl banners in Denver, providing businesses and organizations with high-quality promotional signage solutions. The company's enhanced banner printing capabilities aim to serve the growing demand for outdoor advertising and event signage throughout the Denver metropolitan area.
Denver Print Company [https://maps.google.com/maps?ll=39.729074,-105.001218&z=16&t=h&hl=en&gl=PH&mapclient=embed&cid=7412249110862506011]specializes in custom vinyl banner printing, offering a range of options including hemmed edges,…
Yard Signs in Denver Proudly Offered by Denver Print Company
Image: https://www.globalnewslines.com/uploads/2025/02/1740762415.jpg
Denver Print Company, a leading provider of printing services in the Denver metropolitan area, has expanded its offerings to include a comprehensive range of yard signs in Denver.
Denver Print Company [https://www.denverprintingcompany.com/yard-signs/], a leading provider of printing services in the Denver metropolitan area, has expanded its offerings to include a comprehensive range of yard signs in Denver. This development brings professional, custom-designed yard signs to local businesses, politicians, and individuals…
Yard Signs in Denver Now Offered by Denver Print Company
Image: https://www.globalnewslines.com/uploads/2025/02/1739181424.jpg
Denver, CO - Denver Print Company [https://www.denverprintingcompany.com/yard-signs/], a leading printing service provider, is proud to announce the expansion of their product line to include high-quality yard signs in Denver. This new offering aims to meet the growing demand for effective outdoor signage solutions in the Mile High City and surrounding areas.
David Cowell, CEO of Denver Print Company, states, "Our team is excited to bring our expertise in printing to…
Denver Pain Management Clinic Now Expands Pain Management Clinic Services In Den …
Image: https://www.globalnewslines.com/uploads/2025/01/1737464973.jpg
Denver Pain Management Clinic, a leading provider of chronic pain management in Colorado, has expanded its services as a comprehensive pain clinic in Denver.
Denver Pain Management Clinic [https://denverpainmanagementclinic.com/], a leading provider of chronic pain management in Colorado, has expanded its services as a comprehensive pain clinic in Denver. The clinic, located at 455 Sherman St., Suite 450, Denver, CO 80203, offers innovative pain solutions to address the growing need…
Stem Cell Therapy For Back Pain in Denver Now Offered by Denver Regenerative Med …
Image: https://www.globalnewslines.com/uploads/2024/12/1734971815.jpg
Denver, CO - Denver Regenerative Medicine [https://maps.google.com/maps?ll=39.723326,-104.985225&z=16&t=h&hl=en&gl=PH&mapclient=embed&cid=7591670023696341465], under the leadership of Dr. Joel Cherdack, is excited to introduce a breakthrough treatment for individuals suffering from chronic back pain. The clinic has developed a unique procedure that combines adipose and bone marrow-derived stem cells, resulting in faster recovery times and reduced residual pain for patients.
Dr. Joel Cherdack, Founder and CEO of Denver Regenerative Medicine, emphasized the significance of this development,…